VoxCell BioInnovation, a Canadian biotechnology company, has appointed Graham Craig as chief commercial officer to lead its commercial strategy, including global business development, strategic partnerships and go-to-market execution. Mr Craig joins VoxCell from AbCellera, where he was director of corporate development, and has more than 18 years’ experience in commercialisation and strategic partnerships in the pharma and biotech sectors. VoxCell is developing vascularised 3D tissue models, amid increasing pharmaceutical industry investment in new approach methodologies (NAM). The objective is to help drug developers generate more human-relevant data earlier, accelerating drug development and personalised medicine.
VoxCell announced the appointment on 27 January 2026.
Copyright 2026 Evernow Publishing Ltd.